Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W K Jones

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Basic Research in Cardiology|December 2, 1998
The nitric oxide hypothesis of late preconditioningR Bolli, B Dawn, X L Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host diseaseH Sakamoto, J Michaelson, W K Jones, et al.
The Journal of Clinical Investigation|October 15, 1996
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heartW K Jones, I L Grupp, T Doetschman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 16, 2001
Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1J M Pass, J Gao, W K Jones, et al.
The Journal of Biological Chemistry|October 5, 1992
Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitroT K Sampath, J C Maliakal, P V Hauschka, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase geneY Guo, W K Jones, Y T Xuan, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Basic Research in Cardiology|December 2, 1998
The nitric oxide hypothesis of late preconditioningR Bolli, B Dawn, X L Tang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host diseaseH Sakamoto, J Michaelson, W K Jones, et al.
The Journal of Clinical Investigation|October 15, 1996
Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heartW K Jones, I L Grupp, T Doetschman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 16, 2001
Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1J M Pass, J Gao, W K Jones, et al.
The Journal of Biological Chemistry|October 5, 1992
Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitroT K Sampath, J C Maliakal, P V Hauschka, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 1999
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase geneY Guo, W K Jones, Y T Xuan, et al.
Pageof 5